Use of aspirin for primary and secondary prevention of cardiovascular disease in diabetic patients in an ambulatory care setting in Spain
2007

Aspirin Use for Heart Disease Prevention in Diabetic Patients

Sample size: 4140 publication Evidence: moderate

Author Information

Author(s): Sicras-Mainar Antoni, Navarro-Artieda Ruth, Rejas-Gutiérrez Javier, Fernández-de-Bobadilla Jaime, Frías-Garrido Xavier, Ruiz-Riera Rafael

Primary Institution: Badalona Serveis Assistencials SA

Hypothesis

This study aims to determine the use of aspirin and assess the achievement of therapeutic targets in diabetic patients for primary and secondary prevention of cardiovascular disease.

Conclusion

Aspirin treatment is underused for primary prevention in diabetic patients, and there is a need to improve the achievement of therapeutic targets.

Supporting Evidence

  • 79.1% of patients were in primary prevention and 20.9% in secondary prevention.
  • Aspirin was prescribed to 20.8% in primary prevention and 60.8% in secondary prevention.
  • Achievement of therapeutic targets was 48.0% for blood pressure and 59.8% for cholesterol.

Takeaway

Doctors should give more aspirin to diabetic patients to help prevent heart problems, but many aren't getting it.

Methodology

A retrospective, observational study including patients aged 18 and older with diabetes mellitus from four primary care centers.

Potential Biases

Potential biases due to the observational nature of the study and the reliance on medical records.

Limitations

The study's retrospective design and potential lack of representativeness of the general primary care population in Spain.

Participant Demographics

Mean age was 64.1 years, with 49.3% being men.

Statistical Information

P-Value

p = 0.001

Confidence Interval

95% CI: 77.7–80.5%

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2296-8-60

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication